Abstract
Infants and children who manifest motor dysfunction early in life have decreased ability to interact with their environment which results in less learning opportunities; hence, the consequent cognitive impairment often seen in these circumstances. During this period of brain growth, the brain plasticity allows the rewiring and the creation of new synapses that would compensate for the motor and cognitive deficits [1]. Therefore, early intervention to limit the physical disability and encourage motility, especially before the age of three has the potential to increase the chances of limiting or overcoming further developmental disabilities and promoting alternative learning methods to accomplish challenging tasks.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Staudt M. Brain plasticity following early life brain injury. Semin Perinatol. 2010;34:87–92.
Rosenbaum P. Cerebral palsy: what parents and doctors want to know? Br Med J. 2003;326:970–4.
Russman BS, Ashwal S. Evaluation of the child with cerebral palsy. Semin Pediatr Neurol. 2004;11(1):47–57.
Palisano RJ, Snider LM, Orlin MN. Recent advances in physical and occupational therapy for children with cerebral palsy. Semin Pediatr Neurol. 2004;11(1):66–77.
Damiano DL. Activity, activity, activity: rethinking our physical therapy approach to cerebral palsy. Phys Ther. 2006;86(11):1534–40.
Mahoney G, Robinson C, Fewell RR. The effects of early motor intervention on children with down syndrome or cerebral palsy: a field-based study. J Dev Behav Pediatr. 2001;22(3):153–62.
Werner D. Disabled village children – a guide for community health workers, rehabilitation workers, and families. 2nd ed. Palo Alto, CA: The Hesperian Foundation; 2009.
Rosenbaum P. The definition and classification of cerebral palsy: are we any further ahead in 2006? NeoReviews. 2006;7:e569–74.
Shevell MI, Bodensteiner JB. Cerebral palsy: defining the problem. Semin Pediatr Neurol. 2004;11(1):2–4.
Shevell MI. The “bermuda triangle” of neonatal neurology: cerebral palsy, neonatal encephalopathy, and intrapartum asphyxia. Semin Pediatr Neurol. 2004;11(1):24–30.
Centers for Disease Control and Prevention (CDC) (2006) Learn the signs, act early: cerebral palsy fact sheet. http://www.cdc.gov/actearly. Accessed 17 Nov 2010.
Tilton AH. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol. 2004;11(1):58–65.
Palisano R, Rosenbaum P, Bartlett D. and Livingston M (2007) Gross motor function classification system – expanded and revised. Can child centre for childhood disability research, McMaster University. http://motorgrowth.canchild.ca/en/GMFCS/resources/GMFCS-ER.pdf. Accessed 13 Dec 2010.
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23.
Centers for Disease Control and Prevention (CDC) (2004) Cerebral palsy. http://www.cdc.gov/ncbddd/dd/cp2.htm. Accessed 17 Nov 2010.
Krigger KW. Cerebral palsy: an overview. Am Fam Physician. 2006;73(1):91–100.
Taylor F, National Institute of Neurological Disorders and Stroke (U.S.), Office of Science and Health Reports. Cerebral palsy: hope through research. Bethesda, MD: The Institute; 2001. Accessed http://www.ninds.nih.gov/disorders/cerebral_palsy/detail_cerebral_palsy.htm#154403104.
Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P. Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol. 2006;34(1):1–6.
Gerszten PC, Albright L, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg. 1998;88(6):1009–13.
Nuttin B, Ivanhoe C, Albright L, Dimitrijevic M, Saltuari L. Intrathecal baclofen therapy for spasticity of cerebral origin: cerebral palsy and brain injury. Neuromodulation. 1999;2(2):120–32.
Koman LA, Smith BP, Balkrishnan R. Spasticity associated with cerebral palsy in children. Pediatric Drugs. 2003;5(1):11–23.
Bhidayasiri R. Dystonia: genetics and treatment update. Neurologist. 2006;12(2):74–85.
Barry MJ, Albright L, Shultz BL. Intrathecal baclofen therapy and the role of the physical therapist. Pediatr Phys Ther. 2000;12:77–86.
Roubertie A, Echenne B, Cif L, Vayssiere N, Hemm S, Coubes P. Treatment of early-onset dystonia: update and a new perspective. Childs Nerv Syst. 2000;16:334–40.
McLean WE, Hartley SL. Down syndrome. In: Salkind NJ, editor. Encyclopedia of human development (Vol I). Thousand Oaks, CA: Sage Publications; 2006. p. 394–6.
Hooper SR, Mills C. Developmental processes and factors affecting development. In: Hooper SR, Unmansky W, editors. Young children with special needs. New Jersey: Pearson Education; 2004. p. 38–89.
Dennis CW, Schlough KA. Gross motor development. In: Hooper SR, Unmansky W, editors. Young children with special needs. New Jersey: Pearson Education; 2004. p. 224–67.
Barry, M. (2001). Evidence-based practice in pediatric physical therapy. (11 ed., Vol. 9, p. 38). Ohio: Magazine of Physical Therapy..
Damiano, D., Dodd, K., & Taylor, N. (2002). Should we be testing and training muscle strength in cerebral palsy?. (44 ed., Vol. 1, pp. 68-72).
Mayston M. Evidence-based physical therapy for the management of children with cerebral palsy. Dev Med Child Neurol. 2005 Dec;47(12):795. PubMed PMID: 16288666.
Guralnick MJ. Early intervention for children with intellectual disabilities: current knowledge and future prospects. J Appl Res Intellect Disabil. 2005;18:313–24.
Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J. The multidisciplinary management of Duchenne muscular dystrophy. Curr Paediatr. 2005;15(4):292–300.
Merlini L, Cicognani A, Malaspina E, Gennari M, Gnudi S, Talim B, Franzoni E. Early prednisone treatment in Duchenne muscular dystrophy. Muscle Nerve. 2003;27(2):222–7.
National Center for Biotechnology Information, U.S. National Library of Medicine (2010). Guillain–Barré syndrome. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001704/. Accessed 27 Apr 2011.
Ryan MM. Guillain–Barré syndrome in childhood. J Paediatr Child Health. 2005;41(5–6):237–41.
Sladky JT. Guillain–Barré syndrome in children. J Child Neurol. 2004;19(3):191–200.
Kanra G, Ozon A, Vajsar J, Castagna L, Secmeer G, Topaloglu H. Intravenous immunoglobulin treatment in children with Guillain–Barré syndrome. Eur J Paediatr Neurol. 1997;1:7–12.
Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain–Barré syndrome. Cochrane Database Syst Rev 2010;(6):CD002063.
World Health Organization (2011) Poliomyelitis. http://www.who.int./topics/poliomyelitis/en/. Accessed 29 Apr 2011.
National Center for Biotechnology Information, U.S. National Library of Medicine (2009). Poliomyelitis. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002375/. Accessed 29 Apr 2011.
Center for Disease Control and Prevention (CDC) (2000). Polio vaccine: what you need to know. http://www.immunize.org/vis/ipv-00.pdf. Accessed 29 Apr 2011.
Mackay MT. Stroke in children. Aust Fam Physician. 2007;36(11):896–902.
Scheer J. Stroke recovery and OT: finding and using the evidence to inform practice. OT Practice. 2007;12(5):23–5.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sinno, D., Charafeddine, L., Mikati, M. (2012). Enhancing Childhood Development in Children with Cerebral Palsy and Other Disorders. In: Enhancing Early Child Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4827-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4827-3_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4826-6
Online ISBN: 978-1-4614-4827-3
eBook Packages: MedicineMedicine (R0)